Back to Search
SAID UDDIN, M.D
M.D
Internal Medicine Physician
NPI: 1205938867IndividualAccepts Medicare
Education
OTHER
Class of 1988
Research & Publications (20)
Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.
PMID 19621391·Int J Cancer·2010
7-preclinical
Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.
PMID 19636294·Lab Invest·2009
7-preclinical
Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells.
PMID 19557642·Leuk Lymphoma·2009
8-other
Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins.
PMID 19240159·Mol Cancer Ther·2009
8-other
A national analysis of the relationship between hospital volume, academic center status, and surgical outcomes for abdominal hysterectomy done for leiomyoma.
PMID 19476796·J Am Coll Surg·2009
8-other
Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
PMID 19520793·Carcinogenesis·2009
8-other
Bacterial contaminants in carbonated soft drinks sold in Bangladesh markets.
PMID 19232446·Int J Food Microbiol·2009
8-other
High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
PMID 19491830·Am J Gastroenterol·2009
7-preclinical
Antioxidant and antimicrobial effects of the mangrove tree Heritiera fomes.
PMID 19413115·Nat Prod Commun·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11301 FALLBROOK DR
HOUSTON, TX 77065 - Phone
- (281) 897-9966
Quick Facts
- NPI
- 1205938867
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile